Study Condition(s): Psoriasis

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)

Study Alias: RHBS

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02561806 {{ currentLocaleObject.registryAnchorText }}

Withdrawn Active, not recruiting

Study Purpose

The main purpose of this study is to evaluate the efficacy of the study drug ixekizumab compared to ustekinumab in participants with moderate-to-severe-plaque psoriasis

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

18+ years

Time Commitment

Your participation could last up to 52 weeks plus a minimum of 12 weeks for post treatment follow up visits and include 18 required visits to the study center
  • Participant must have chronic plaque psoriasis for at least 6 months before the start of the study

  • Participant must agree to use reliable method of birth control during the study; women must continue using birth control for at least 15 weeks after stopping study treatment

  • Participant cannot have forms of psoriasis other than plaque psoriasis

  • Participant must not have received ustekinumab (Stelara) or already been treated with ixekizumab or another drug with a similar mode of action

  • Participant must be willing to avoid excessive sun exposure or use of tanning booths for at least 4 weeks prior to enrollment and during the study

  • Participant must not have a known allergy or hypersensitivity to latex

  • Participant must not have had any major surgery within 8 weeks of baseline or will require such during the study

  • Female participant must not be pregnant, lactating or breast-feeding

Where to Participate

51 locations are currently available of 60 planned
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}} {{site.getSiteCTALabel() | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.